Brief: Vertex To Acquire Crinetics Pharmaceuticals In $10 Billion Deal

Crinetics Pharmaceuticals

06/07/2026 21:16

July 6 (Reuters) - 
VERTEX TO ACQUIRE CRINETICS PHARMACEUTICALS
VERTEX TO BUY CRINETICS FOR $85 PER SHARE IN $10 BILLION DEAL
VERTEX WILL ACQUIRE CRINETICS FOR $85.00 PER SHARE IN CASH
VERTEX TO FINANCE DEAL USING CASH ON HAND & DEBT
DEAL EXPECTED TO BE ACCRETIVE VERTEX'S TO NON-GAAP OPERATING INCOME IN 2029
FINANCING SUPPORTED BY $4.5 BILLION OF FULLY COMMITTED BRIDGE FINANCING FROM BANK OF AMERICA, MORGAN STANLEY SENIOR FUNDING
Source text: ID:nBw1b3TBba
Further company coverage: CRNX.OVRTX.O

 ((Reutersbriefs@thomsonreuters.com;))